Showing 1641-1650 of 7031 results for "".
CoolSculpting Circumferential Treatment Video
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/coolsculpting-circumferential-treatment-video/19442/Dr. Brian Zelickson of Edina, MN is demonstrating on a patient the benefits of using a circumferential treatment method with CoolSculpting for maximum results. Dr. Zelickson details the benefits of this type of treatment and the results his patient received.Hoya ConBio - Non-ablative Skin Rejuvination for Wrinkles and Acne Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-non-ablative-skin-rejuvination-for-wrinkles-and-acne-scars/19459/A study with Dr. Paul Friedman reveals why the Medlite C6 is fast becoming the laser of choice for skin renewal. How to use the Medlite is discussed and demonstrations are shown.Artefill Overview
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aretfille/19521/A description of Artefill (polymethylmethacrylate (PMMA) microspheres and bovine collagen), patient assessment/consultation, injection technique for dermal filler, and aesthetic progression .Spectra Peel for Acne
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/spectra-peel/19522/Demonstration of SpectraPeel for acne and rejuvenation, using pulse and Q-switched modes. Presented by Kevin Deuplechain, MDAGEP Following a New Weight Loss Regimen
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agep-following-a-new-weight-loss-regimen/23719/A 55-Year-Old Man with Erythematous Papules Following a New Weight Loss RegimenReviewing the Role of JAK Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/programs/dermconsult/reviewing-the-role-of-jak-inhibitors-in-atopic-dermatitis/13460/The FDA recently approved two oral JAK-1 inhibitors for mild-to-severe atopic dermatitis. Here's what we need to know about these new options.Addressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.Laser Adoption in Dermatology
https://practicaldermatology.com/series/c-suite-chats/laser-adoption-dermatology/26535/Pavel Efremkin, PhD, Founder and CEO of Aerolase, discusses the state of the laser market in dermatology and the various applications of new technology in the field.Clascoterone: A Novel Topical Anti-androgen for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/clascoterone-a-novel-topical-anti-androgen-for-the-treatment-of-acne/23133/For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.